Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection

Significant advances have been made in nucleos(t)ide analogue (NA) therapy to treat chronic hepatitis B, and this therapy reduces the risk of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in some patients. However, whether NAs can also prevent recurrence after radical resection of H...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ke, Yang, Wang, Lin, Li, Le-Qun, Zhong, Jian-Hong
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2014
Témata:
Minireviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179144/
https://ncbi.nlm.nih.gov/pubmed/25276281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i9.652
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky